ARCHIVES

In Brief: Gramm-Rudman-Hollings Could Slash NCI Budget By $650 Million; Holleb Retires From ‘Ca’

This article is from The Cancer Letter archive.

Vol. 16 No. 30 | July 27, 1990

Download PDF Visit The Full Archive

Related Articles

Anticancer Vaccine Trials Due In Three-Four Years; Virus Research Opportunities Described

July 25, 1975

In Brief: Board Subcommittee Meetings On Comprehensive Centers Postponed; FDA Committee Uncharted

March 10, 1978

Scientists Falsified Research, ORI Says

July 5, 1996

Obey Continue Crusade On Carcinogenesis, Attack On DCCP, Shubik

April 1, 1977

Bevacizumab And Irinotecan May Increase Survival Of GBM

October 26, 2007

In Brief: House Passes appropriations Bill; Senate Markup in Late Summer; Kirschstein Acting NIH Director

July 9, 1993